Alexandria Real Estate Equities, Inc. celebrates its 30th anniversary as a pioneering developer of collaborative mega-campuses for life science, agtech and advanced technology industries. Founded in Pasadena on January 5th, 1994, the publicly traded company is recognized as the only pure-play REIT focused solely on life science.
Executive Chairman and Founder Joel S. Marcus reflects on their early recognition of the potential within this growing industry: “Thirty years ago we saw the remarkable potential of life science and today we are proud to be trusted partners to leaders in this field.” Alexandria’s essential Labspace assets have played a crucial role in advancing groundbreaking therapies and cures for diseases with half of all FDA-approved treatments since 2013 coming from tenants within their campuses.
Since its IPO in May 1997 through December 31st,2023,Alexandria has achieved an impressive TSR (total shareholder return)of1 ,512%, outperforming major indices such as FTSE Nareit Equity Health Care Index (980%)and MSCI US REIT Index(792%).
The image featured showcases Alexandria’s New York City campus which continues to drive innovation within these industries.
